Abstract:High and low body mass index (BMI) may increase the risk of Alzheimer’s disease (AD) in mid‐life (age<65) and late‐life (age≥65) respectively. However, it is still not fully understood about the associations of BMI changes with AD progression as well as how APOE‐ε4 allele modulates their relationships in mid‐life and late‐life. In this study, we aimed to determine how BMI changes and APOE‐ε4 allele relate to longitudinal β‐amyloid (Aβ) accumulation, tau aggregation, neurodegeneration and cognitive decline in mid‐life and late‐life. We examined 325 cognitively unimpaired and 391 mild cognitive impairment Alzheimer’s Disease Neuroimaging Initiative participants with longitudinal 18F‐florbetapir (FBP) Aβ PET and BMI measurements. Among of them, 486, 707 and 710 had longitudinal 18F‐fluorodeoxyglucos (FDG) PET, adjusted hippocampal volume (aHCV) and memory scores, and 246 participants had follow‐up 18F‐flortaucipir (FTP) tau PET data measured at a median of 5.5 years post baseline FBP scan. We investigated the associations of BMI slopes with longitudinal changes of AD typical summary cortical region FBP PET and FDG PET, aHCV and memory scores, and follow‐up Temporal‐metaROI FTP PET in different Aβ status (Aβ‐ and Aβ+), APOE‐ε4 status (carriers and non‐carriers), age (mid‐life and late‐life). We found faster BMI decreases accelerated the rates of Aβ accumulation (Fig.1D, standardized β (βstd) = ‐0.29, p = 0.002), hypometabolism (Fig.3D, βstd = 0.24, p = 0.03), hippocampal atrophy (Fig.3H, βstd = 0.29, p = 0.002), and memory decline (Fig.4D, βstd = 0.28, p = 0.005), and induced marginally higher follow‐up tau deposition (Fig.2D, βstd = ‐0.26, p = 0.09) in Aβ+ late‐life APOE‐ε4 non‐carriers but not in APOE‐ε4 carriers. In contrast, BMI increases were related to faster (Fig.1C, βstd = 0.80, p < 0.001) rates of Aβ accumulation in Aβ+ mid‐life APOE‐ε4 carriers but not in APOE‐ε4 non‐carriers. These findings suggest that weight increase in mid‐life APOE‐ε4 carriers and weight loss in late‐life APOE‐ε4 non‐carriers are environmental risk factors of AD, highlighting the importance of tracking BMI data in Aβ+ individuals.

Metabolically healthy obesity reduces the risk of Alzheimer's disease in elders: a longitudinal study

The risk of Alzheimer’s disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study

The risk of Alzheimer's disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study

Metabolically healthy obesity and lipids may be protective factors for pathological changes of alzheimer’s disease in cognitively normal adults

Different associations between body mass index and Alzheimer's markers depending on metabolic health

Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease

Metabolically Healthy Obesity is Associated with Longitudinal Changes in High-Density Lipoprotein Cholesterol in Chinese Adults

Late-life Obesity is a Protective Factor for Prodromal Alzheimer's Disease: a Longitudinal Study.

Metabolically Healthy Obesity and Risk of Stroke: a Meta-Analysis of Prospective Cohort Studies

Obesity reduces hippocampal structure and function in older African Americans with the APOE-ε4 Alzheimer's disease risk allele

Metabolically Healthy Obesity Increases the Prevalence of Stroke in Adults Aged 40 Years or Older: Result from the China National Stroke Screening Survey

The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging

Is metabolic-healthy obesity associated with risk of dementia? An age-stratified analysis of the Whitehall II cohort study

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study

Long-term metabolic risk for the metabolically healthy overweight/obese phenotype

Metabolically healthy obesity increased diabetes incidence in a middle‐aged and elderly Chinese population

Metabolic dysfunctions predict the development of Alzheimer's disease: Statistical and machine learning analysis of EMR data

Weight increases and decreases show distinct association with Alzheimer’s Disease in different age and APOE‐ε4 status

Metabolic-associated steatotic liver disease and risk of Alzheimer's disease: a real-world retrospective cohort study

Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: the CABLE Study

Associations between dietary one-carbon metabolism nutrients, genetic risk, with Alzheimer's disease: a prospective cohort study